Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2)
Condition: Leprosy Interventions: Drug: BE-PEP (Bedaquiline); Drug: SDR-PEP; Drug: BE-PEP (Rifampicine) Sponsors: Institute of Tropical Medicine, Belgium; Damien Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials